1. Home
  2. NNVC vs TURN Comparison

NNVC vs TURN Comparison

Compare NNVC & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNVC
  • TURN
  • Stock Information
  • Founded
  • NNVC 2005
  • TURN 1981
  • Country
  • NNVC United States
  • TURN United States
  • Employees
  • NNVC N/A
  • TURN N/A
  • Industry
  • NNVC Biotechnology: Pharmaceutical Preparations
  • TURN Finance/Investors Services
  • Sector
  • NNVC Health Care
  • TURN Finance
  • Exchange
  • NNVC Nasdaq
  • TURN Nasdaq
  • Market Cap
  • NNVC 22.5M
  • TURN 49.6M
  • IPO Year
  • NNVC N/A
  • TURN N/A
  • Fundamental
  • Price
  • NNVC $1.44
  • TURN $8.00
  • Analyst Decision
  • NNVC
  • TURN
  • Analyst Count
  • NNVC 0
  • TURN 0
  • Target Price
  • NNVC N/A
  • TURN N/A
  • AVG Volume (30 Days)
  • NNVC 112.7K
  • TURN 33.2K
  • Earning Date
  • NNVC 11-13-2025
  • TURN 02-26-2018
  • Dividend Yield
  • NNVC N/A
  • TURN N/A
  • EPS Growth
  • NNVC N/A
  • TURN N/A
  • EPS
  • NNVC N/A
  • TURN 0.29
  • Revenue
  • NNVC N/A
  • TURN $488,011.00
  • Revenue This Year
  • NNVC N/A
  • TURN N/A
  • Revenue Next Year
  • NNVC N/A
  • TURN N/A
  • P/E Ratio
  • NNVC N/A
  • TURN $17.34
  • Revenue Growth
  • NNVC N/A
  • TURN 277.43
  • 52 Week Low
  • NNVC $0.94
  • TURN $3.12
  • 52 Week High
  • NNVC $1.92
  • TURN $5.01
  • Technical
  • Relative Strength Index (RSI)
  • NNVC 47.26
  • TURN 91.31
  • Support Level
  • NNVC $1.42
  • TURN $4.60
  • Resistance Level
  • NNVC $1.47
  • TURN $8.74
  • Average True Range (ATR)
  • NNVC 0.06
  • TURN 0.24
  • MACD
  • NNVC 0.01
  • TURN 0.31
  • Stochastic Oscillator
  • NNVC 60.00
  • TURN 82.51

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

About TURN 180 Degree Capital Corp.

180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.

Share on Social Networks: